Vaccine-Related Myocarditis Severity Triage Score (VRMST) Calculator

Clinical calculation support · Verify results before clinical use

Clinical assessment inputs

Enter the available clinical findings. This proposed score is not validated and must not replace urgent clinical assessment.

— Score

Context only; this variable does not contribute points.

Enter a measured LVEF greater than 0% and no more than 100%.

Use the assay-specific upper limit of normal; must be greater than zero.

How to interpret this calculator

This calculator reproduces the point assignments supplied in the original code as a proposed educational triage aid. It has not been established as a validated prognostic score for vaccine-associated myocarditis.

Point assignments implemented

FindingPoints
SBP <90 mmHg or use of inotropes/vasopressors6
LVEF <40%5
LVEF 40–49%3
Sustained VT/VF or high-grade AV block4
Pericardial effusion with tamponade4
Troponin / assay ULN ≥10; ≥3 to <10; ≥1 to <33; 2; 1
CRP ≥50; ≥10 to <50 mg/L2; 1
ECG ST elevation or diffuse ST/T changes1
Chest pain at rest, dyspnea, or syncope (one combined item)1

Original proposed bands

0–3: lower score band; 4–7: moderate score band; ≥8: severe score band. These thresholds are retained from the supplied code, not validated clinical cutoffs. They are not mortality estimates and do not replace assessment of the patient's overall condition.

Clinical safety points

  • Hemodynamic instability, sustained ventricular arrhythmia, advanced AV block, tamponade, or rapidly deteriorating heart failure warrants urgent clinical assessment regardless of the calculated total.
  • Interpret ECG, serial cardiac troponin, inflammatory markers, echocardiography, and cardiac magnetic resonance in the appropriate clinical context.
  • Consider alternative causes of myocardial injury and myocarditis; temporal association with vaccination alone does not establish causality.

References

Drazner MH, Bozkurt B, Cooper LT, et al. 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. Journal of the American College of Cardiology. 2024;85(4). DOI: 10.1016/j.jacc.2024.10.080.
Centers for Disease Control and Prevention (CDC). Clinical considerations: Myocarditis and pericarditis after receipt of COVID-19 vaccines among adolescents and young adults. Official CDC guidance.

The sources above support clinical evaluation and recognition of high-risk myocarditis features. They do not validate the VRMST point weights, cutoffs, or score bands.

Clinical disclaimer: This calculator is an educational aid based on a proposed, unvalidated score. It is not a diagnostic tool, validated prognostic model, or substitute for clinician assessment and local protocols. Do not use a low score to reassure, discharge, or defer escalation when symptoms, vital signs, ECG, biomarkers, imaging, or clinical trajectory are concerning.